Literature DB >> 16783379

An inherited mutation leading to production of only the short isoform of GATA-1 is associated with impaired erythropoiesis.

Luciana M Hollanda1, Carmen S P Lima, Anderson F Cunha, Dulcinéia M Albuquerque, José Vassallo, Margareth C Ozelo, Paulo P Joazeiro, Sara T O Saad, Fernando F Costa.   

Abstract

Acquired somatic mutations in exon 2 of the hematopoietic transcription factor GATA-1 have been found in individuals with Down syndrome with both transient myeloproliferative disorder and acute megakaryoblastic leukemia. These mutations prevent the synthesis of the full-length protein but allow the synthesis of its short isoform, GATA-1s. Experiments in mice suggest that GATA-1s supports normal adult megakaryopoiesis, platelet formation and erythropoiesis. Here we report a mutation, 332G --> C, in exon 2 of GATA1, leading to the synthesis of only the short isoform in seven affected males from two generations of a family. Hematological profiles of affected males demonstrate macrocytic anemia, normal platelet counts and neutropenia in most cases. Altogether, data suggest that GATA-1s alone, produced in low or normal levels, is not sufficient to support normal erythropoiesis. Moreover, this is the first study to indicate that a germline splicing mutation does not lead to leukemia in the absence of other cooperating events, such as Down syndrome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16783379     DOI: 10.1038/ng1825

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  79 in total

1.  Long-term outcome of hemizygous and heterozygous carriers of a germline GATA1 (G208R) mutation.

Authors:  Ulrich Dührsen; Christian P Kratz; Christian Flotho; Thomas Lauenstein; Martin Bommer; Erika König; Günter Brittinger; Hermann Heimpel
Journal:  Ann Hematol       Date:  2010-10-05       Impact factor: 3.673

2.  Acute megakaryoblastic leukemia without GATA1 mutation after transient myeloproliferative disorder in an infant without Down syndrome.

Authors:  Hiroto Inaba; Margherita Londero; Scott H Maurer; Mihaela Onciu; Yubin Ge; Jeffrey W Taub; Jeffrey E Rubnitz; Susana C Raimondi
Journal:  J Clin Oncol       Date:  2011-01-04       Impact factor: 44.544

3.  The hypomorphic Gata1low mutation alters the proliferation/differentiation potential of the common megakaryocytic-erythroid progenitor.

Authors:  Barbara Ghinassi; Massimo Sanchez; Fabrizio Martelli; Giovanni Amabile; Alessandro Maria Vannucchi; Giovanni Migliaccio; Stuart H Orkin; Anna Rita Migliaccio
Journal:  Blood       Date:  2006-10-12       Impact factor: 22.113

4.  Cyclin D-Cdk4 is regulated by GATA-1 and required for megakaryocyte growth and polyploidization.

Authors:  Andrew G Muntean; Liyan Pang; Mortimer Poncz; Steven F Dowdy; Gerd A Blobel; John D Crispino
Journal:  Blood       Date:  2007-02-22       Impact factor: 22.113

5.  SCL and associated proteins distinguish active from repressive GATA transcription factor complexes.

Authors:  Tamara Tripic; Wulan Deng; Yong Cheng; Ying Zhang; Christopher R Vakoc; Gregory D Gregory; Ross C Hardison; Gerd A Blobel
Journal:  Blood       Date:  2008-11-14       Impact factor: 22.113

6.  Analysis of disease-causing GATA1 mutations in murine gene complementation systems.

Authors:  Amy E Campbell; Lorna Wilkinson-White; Joel P Mackay; Jacqueline M Matthews; Gerd A Blobel
Journal:  Blood       Date:  2013-05-23       Impact factor: 22.113

Review 7.  Expression of different functional isoforms in haematopoiesis.

Authors:  Godfrey Grech; Joel Pollacco; Mark Portelli; Keith Sacco; Shawn Baldacchino; Justine Grixti; Christian Saliba
Journal:  Int J Hematol       Date:  2013-12-01       Impact factor: 2.490

Review 8.  Erythro-megakaryocytic transcription factors associated with hereditary anemia.

Authors:  John D Crispino; Mitchell J Weiss
Journal:  Blood       Date:  2014-03-20       Impact factor: 22.113

9.  Developmental Stage-Specific Manifestations of Absent TPO/c-MPL Signalling in Newborn Mice.

Authors:  Viola Lorenz; Haley Ramsey; Zhi-Jian Liu; Joseph Italiano; Karin Hoffmeister; Sihem Bihorel; Donald Mager; Zhongbo Hu; William B Slayton; Benjamin T Kile; Martha Sola-Visner; Francisca Ferrer-Marin
Journal:  Thromb Haemost       Date:  2017-12-06       Impact factor: 5.249

Review 10.  Malignancy in children with trisomy 21.

Authors:  Karen R Rabin; James A Whitlock
Journal:  Oncologist       Date:  2009-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.